Related Experiment Video
Updated: Oct 8, 2026

Adaptation at the Extremes of Life: Experimental Evolution with the Extremophile Archaeon Sulfolobus acidocaldarius
Published on: June 14, 2024
Differences between Desulfovibrio desulfuricans intestinal strains with respect to their ability of sulphasalazine
Z Dzierzewicz1, B Cwalina, D Kuśmierz
1Department of Molecular Biology, Biochemistry and Biopharmacy Medical University of Silesia, 1 Narcyzów Str., 41-200 Sosnowiec.
Abstract:
In presented study, differences among six intestinal Desulfovibrio desulfuricans strains were investigated regarding their ability of sulphasalazine (SAS) biotransformation. Bacterial strains were incubated (24 or 48 h) in liquid medium supplemented with SAS (12.2-150 microM). It has been demonstrated that investigated D. desulfuricans strains converted SAS with various rates, depending on the strain used and on time of drug contact with bacterial cells. Significantly different (50% coefficient of variability) were the maximum rates of SAS biotransformation. It was demonstrated that these rates were strongly dependent on the drug concentration. Increasing SAS concentrations up to about 120 microM caused increase in the drug transformation rate. At higher SAS concentrations this rate remained at the same level or was inconsiderable lower. The strains exposed to SAS for 24 hs transformed this drug with the rate about twice as compared with that observed after 48 h exposition.
Related Concept Videos
Drugs for Treatment of Ulcerative Colitis in IBD
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Sulfur Assimilation
Drug Metabolism: Phase II Reactions
Phase II Reactions: Sulfation and Conjugation with α-Amino Acids
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
